Literatuur
Brunt, T. M., Koeter, M. W., Niesink, R. J., & Brink, W. van den (2012). Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. Psychopharmacology, 220, 751–762.
Croes, E. A., Vogels, N., Pol, P. van der (2014). Factsheet Monitor drugsincidenten 2013. Utrecht: Trimbos-instituut.
Dumont, G. J., Sweep, F. C., Steen, R. van der, Hermsen, R., Donders, A. R., Touw, D. J., Gerven, J. M. van, Buitelaar, J. K., Verkes, R. J. (2009). Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Society for Neuroscience, 4, 359–366.
Goossens, F. X., Frijns, T., Hasselt, N. E. van, & Laar, M. W. van (2014). Het grote uitgaansonderzoek 2013. Uitgaanspatronen, middelengebruik en risicogedrag onder uitgaande jongeren en jongvolwassenen. Utrecht: Trimbos-instituut.
Gowing, L. R., Henry-Edwards, S. M., Irvine, R. J., & Ali, R. L. (2002). The health effects of ecstasy: A literature review. Drug and Alcohol Review, 21, 53–63.
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003). The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’). Pharmacological Reviews, 55, 463–508.
Gudelsky, G. A., & Yamamoto, B. K. (2003). Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine. Methods in Molecular Medicine, 79, 55-73.
Henry, J. A., Jeffreys, K. J., & Dawling, S. (1992). Toxicity and deaths from 3, 4-methylenedioxymethamphetamine (‘ecstasy’). Lancet, 340, 384–387.
Home Office. (2014). Drug misuse: findings fom the 2013/2014 Crime Survey for England and Wales. https://www.gov.uk/government/publications/drug-misuse-findings-from-the-2013-to-2014-csew/drug-misuse-findings-from-the-201314-crime-survey-for-england-and-wales#extent-and-trends-in-illicit-drug-use-among-adults. Geraadpleegd: 14. Apr. 2015.
Irvine, R. J., Keane, M., Felgate, P., McCann, U. D., Callaghan, P. D., & White, J. M. (2006). Plasma drug concentrations and physiological measures in ‘dance party’ participants. Neuropsychopharmacology, 31, 424–430.
Kalant, H. (2001). The pharmacology and toxicology of ‘ecstasy’(MDMA) and related drugs. Canadian Medical Association Journal, 165, 917–928.
Kiyatkin, E. A., & Sharma, H. S. (2012). Environmental conditions modulate neurotoxic effects of psychomotor stimulant drugs of abuse. International Review of Neurobiology, 102, 147.
Krul, J. (2013). Mass Gathering Medicine at raves: Incidents and substance-related emergencies. Amsterdam: Vrije Universiteit PhD thesis.
Krul, J., Girbes, A. R., & Sanou, B. T. (2012). Increase in serious ecstasy-related incidents in the Netherlands. Lancet, 380, 1385.
Meyer, J. S. (2013). 3, 4-methylenedioxymethamphetamine (MDMA): Current perspectives. Substance Abuse and Rehabilitation, 4, 83.
Nicol, J. J., Yarema, M. C., Jones, G. R., Martz, W., Purssell, R. A., MacDonald, J. C., & Buxton, J. A. (2015). Deaths from exposure to paramethoxymethamphetamine in Alberta and British Columbia, Canada: A case series. Canadian Medical Association Open Access Journal, 3, E83–E90.
Office for National Statistics (2014). Deaths Related to Drug Poisoning in England and Wales, 2013. http://www.ons.gov.uk/ons/dcp171778_375498.pdf. Geraadpleegd: 14. Apr. 2015.
Ovaska, H., Viljoen, A., Puchnarewicz, M., Button, J., Ramsey, J., Holt, D. W., & Wood, D. M. (2008). First case report of recreational use of 2, 5-dimethoxy-4-chloroamphetamine confirmed by toxicological screening. European Journal of Emergency Medicine, 15, 354–356.
Parrott, A. C. (2012). MDMA and temperature: A review of the thermal effects of ‘Ecstasy’in humans. Drug and Alcohol Dependence, 121, 1–9.
Patel, M. M., Belson, M. G., Longwater, A. B., Olson, K. R., & Miller, M. A. (2005). Methylenedioxymethamphetamine (ecstasy)-related hyperthermia. Journal of Emergency Medicine, 29, 451–454.
Poel, A. van der, Doekhie, J., Verdurmen, J., Wouters, M., Korf, D., & Laar, M. van (2010). Feestmeter 2008–2009: uitgaan en middelengebruik onder bezoekers van party’s en clubs. Utrecht: Bonger Instituut voor Criminologie UvA en Trimbos-instituut.
Rietjens, S. J., Hondebrink, L., Westerink, R. H., & Meulenbelt, J. (2012). Pharmacokinetics and pharmacodynamics of 3, 4-methylenedioxymethamphetamine (MDMA): Interindividual differences due to polymorphisms and drug-drug interactions. Critical Reviews in Toxicology, 42, 854–876.
Rooij, A. van, Schoenmakers, T. M., & Van de Mheen, D. (2011). Nationaal prevalentie onderzoek middelengebruik 2009: de kerncijfers. Rotterdam: IVO.
Sample, I. (2015). ‘Superman’ pill deaths spark calls for dangerous-drugs alert system. Guardian, 16 Januari.
Saunders, N., & Doblin, R. (1996). Ecstasy: Dance, trance & transformation. Oakland: Quick American Archives.
Schifano, F., Corkery, J., Naidoo, V., Oyefeso, A., & Ghodse, H. (2010). Overview of amphetamine-type stimulant mortality data-UK, 1997–2007. Neuropsychobiology, 61, 122.
Strobbe, L., Jager, C. P. de, Louwerse, E. S., Rozendaal, F. W. (2007). [Fatal ecstasy intoxication in a 22-year-old man]. Nederlands Tijdschrift voor Geneeskunde, 151, 1690–1694.
Tancer, M. E., & Johanson, C. E. (2001). The subjective effects of MDMA and mCPP in moderate MDMA users. Drug and Alcohol Dependence, 65, 97–101.
Ter Bogt, T. F. T., Gabhainn, S. N., Simons-Morton, B. G., Ferreira, M., Hublet, A., Godeau, E. E., & Richter, M. (2012). Dance is the new metal: Adolescent music preferences and substance use across Europe. Substance Use and Misuse, 47, 130–142.
The Guardian (2014). Clubbers warned of overdose risk from super-strength ecstasy. Guardian, 28 november.
The Local (2015). Sweden confirms four ‘Superman’ drug deaths. http://www.thelocal.se/20150109/more-fatal-superman-drug-use. Geraadpleegd: 14. Apr. 2015.
Torre, R. De La, Farre, M., Ortuno, J., Mas, M., Brenneisen, R., Roset, P. N., & Cami, J. (2000). Non-linear pharmacokinetics of MDMA (‘ecstasy’) in humans. British Journal of Clinical Pharmacology, 49, 104–109.
Torre, R. De La, Farre, M., Roset, P. N., López, C. H., Mas, M., Ortuno, J., & Cami, J. (2000). Pharmacology of MDMA in humans. Annals of the New York Academy of Sciences, 914, 225–237.
Traub, S. J., Hoffman, R. S., & Nelson, L. S. (2002). The ‘Ecstasy’ hangover: Hyponatremia due to 3, 4-methylenedioxymethamphetamine. Journal of Urban Health, 79, 549–555.
Vervaeke, H. (2008). Stimulerende middelen: xtc. In H. Vervaeke (red.), Drugs en alcohol; gebruik, misbruik en verslaving (pp. 245–278). Houten: Bohn Stafleu van Loghum.
Vollenweider, F. X., Gamma, A., Liechti, M., & Huber, T. (1998). Psychological and cardiovascular effects and short-term sequelae of MDMA (‘ecstasy’) in MDMA-naive healthy volunteers. Neuropsychopharmacology, 19, 241–251.
Wouters, M., Nabben, T., Benschop, A., & Korf, D. J. (2014). Drug use trends in Amsterdam nightlife, 2013. Jellinekreeks, 25. Amsterdam: Rozenberg Publishers.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Niesink, R., Brunt, T. & Croes, E. Ecstasy: PMMA, MDMA en hooggedoseerde pillen. Verslav 11, 89–102 (2015). https://doi.org/10.1007/s12501-015-0020-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12501-015-0020-3